Hanaa received her MD in 1993 and her PhD in 2008 from The Suez Canal University in Egypt. She completed her postdoctoral training at UTMB where she received hands-on training in the study of gastrointestinal motility disorders. Hanaa’s experience
of clinical and translational research is in the fields of severe burn injury, scleroderma, constipation, obesity, diabetes, chemotherapy-induced nausea and vomiting, alcohol abuse, electrical stimulation, and electroacupuncture. Hanaa joined
Dr. Abate’s lab in 2013 as a Research Scientist, where she is currently researching the effect of severe burns on adipose tissue dysfunction and glucose metabolism in children, which is funded through Dr. Abate’s Shrine grant.
Education- M.D., 1993, Suez Canal University, Ismailia, Egypt
- Ph.D., 2008, Suez Canal University, Ismailia, Egypt
Awards- 2013, Poster of Distinction, Digestve Disease Week (DDW) - May 18-21 - Orlando, Florida,
- 2010, Young Investigator Travel Award, Joint International Neurogastroenterology and Motility Meeting, August 26-29, 2010, Boston, Massachusetts,
- 2010, Pat Simons Travel Award, Obesity 28th Annual Scientific Meeting, October 8-12, 2010, San Diego, CA,
Publications
Sallam HS, Tumurbaatar B, Zhang W, Tuvdendorj D, Chandalia M, Tempia F, Laezza F, Taglialatela G, Abate N. Peripheral Adipose Tissue Insulin Resistance Alters Lipid Composition and Function of Hippocampal
Synapses. J Neurochem (accepted).
Patel P, Sallam HS, Ali A, Chandalia M, Finnerty CC, Herndon DN, Abate N. Changes in Fat Distribution in Children Following Severe Burn Injury. Metabolic Syndrome and Related Disorders 2014 Sep 11. [Epub ahead of print].
PMID: 25211297.
Abate N, Sallam HS, Rizzo M, Nikolic D, Obradovic M, Bjelogrlic P, Isenovic ER. Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome. Curr Pharm Des. 2014;20(31):4961-9. PMID: 24320036.
Rizvi AA, Nikolic D, Sallam HS, Ferlita A, Butera G, Montalto G, Rizzo M, Abate N. Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Metabolic Syndrome and Related Disorders. 2014 Feb;12(1):1-10.
PMID: 24206170